StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs total assets

Total assets on the balance sheet at the end of each period.

BioAge Labs's total assets was $396.93M at Jun 30, 2026. For fiscal 2025 it was $294.89M, down 17.7% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$294.89M-17.7%
FY2024Dec 31, 2024$358.23M+1281.9%
FY2023Dec 31, 2023$25.92M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$396.93M+23.2%
Q1 FY2026Mar 31, 2026$397.65M+15.7%
Q4 FY2025Dec 31, 2025$294.89M-17.7%
Q3 FY2025Sep 30, 2025$305.09M-9.6%
Q2 FY2025Jun 30, 2025$322.15M+1142.7%
Q1 FY2025Mar 31, 2025$343.84M–
Q4 FY2024Dec 31, 2024$358.23M–
Q3 FY2024Sep 30, 2024$337.38M–
Q4 FY2023Dec 31, 2023$25.92M–

More BioAge Labs figures

See a number that looks wrong?